chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a consumer via Clinic refers to a currently 22 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 18-AUG-2017, the patient was vaccinated with improperly stored dose of LIQUID PEDVAXHIB 1 dose unit ( lot # M047666, Expiry date was not reported) for prophylaxis (product storage error). There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-1801USA000166:
I got the shot at 6pm and felt a bit tired afterwards and my arm was a bit sore. Later that night, I had a fever and was shaking severely. My entire body ached and my neck was especially sore. My eyes hurt and I had trouble focusing them and felt a bit dizzy. The next day I could barely spend anytime sitting or standing up and I laid down for nearly the entire day. I was very sore, tired, and felt foggy. I am still having trouble focusing my eyes today (three days after I received my shot) and I still feel very tired and sore.
Next day patient woke up with low grade fever, chills, back pain, and burning sensation during urination.  Within 3-4 days majority of the patients symptoms have subsided and improved.
General side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (General side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (General side effects). At the time of the report, VACCINATION COMPLICATION (General side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow up received on 08-MAY-2021. It contains NNI.
Localized swelling and erythema left upper leg 10 x 6 cm, minimally warm.
Labored shallow breathing, rapid heartbeat, wheezing, cough, dizziness.
Patient called to inform us that she still has redness, swelling and warmth in the right arm red 9 days after vaccination.  She is not currently having any systemic issues.
4/20/21 hearing loss R ear, ringing in R ear, dizziness, headaches went to ER, then was referred to  ENT- Dr. diagnosed with sudden hearing loss. Recommend steroids (oral or injectable) which she has not yet started Caller reports she will not be getting 2nd vaccine
Information has been received from a licensed practical nurse concerning a 9 week old white male patient with no medical history or allergies who on 01-NOV-2006 at 10:15 am was vaccinated PO with a first dose of ROTATEQ (lot # 655174/0848F). Concomitant vaccination administered that day included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, poliovirus vaccine, Hib conj vaccine (OMPC) (manufacturer unknown) and PREVNAR. Concomitant therapy included 0.9 mL of ZANTAC. There was no illness at the time of vaccination. On 04-NOV-2006 the patient was crampy, drawing legs up as if in pain, shrieking and had a congested nose. These symptoms resolved on 06-NOV-2006. On 06-NOV-2006 at 11:00 am the patient developed diarrhea and was gassy "all day." The patient was crying for 6.5 hours. Unspecified medical attention was sought. The patient's outcome was recovered. There was no product quality complaint involved. The patient did not experience any adverse events after prior vaccination. Additional information is not expected.
Arm injection sight had swelling, redness and pain that lasted 4 to 5 days. Some pain spread to other parts of the body, even after taking Naproxen to help with the inflammation.
pt had high pitch cry for 20 mins & then slept for 10 hrs following the vax;
Pt received second Pfizer COVID-19 vaccine on 5/10/2021. On 5/12, she saw her PCP c/o mid abdomen/esophageal pain after eating breakfast. Advised to go to the ED for more complete blood work. Pt was prescribed famotidine and pt sent home.
Mom call into the clinic regarding a lump on the patient left leg painful to touch, with no redness, no fever.  patient receives the vaccine on 2/20/23.
patient called saying after getting vaccine she developed a hardened, itchy, ball at the site of injection. no fever and the area was not hot to the touch.
Pain in ankle, difficulty putting weight on foot, inflammation in ankle and foot, became immobile.  Went to medical facility and they inspected the foot and took X-rays.  They recommended we go to ER for additional assessments.  Went to ER, they took additional X-rays, took a blood panel, and drew fluid from the inflammation spot.  All tests came back negative, we were released and given a specialist referral.  I went to the specialist a few days later they took additional X-rays and recommended an ultrasound and MRI.  The ultrasound came back negative, and MRI didn't show cause.  12/21 we saw Dr. and we are still working on finding a cause.  As of todays date 1/3/22 cause is unknown inflammation has gone down and I can walk on it but it flares up and is still painful at times.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2021 as dose 1, single (Lot number: ER8734) at the age of 34 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Zoaforte, reaction(s): "Known allergies: Zoaforte", notes: Known allergies: Zoaforte. The following information was reported: CEREBROVASCULAR DISORDER (non-serious) with onset Jul2021, outcome "not recovered", described as "blood vessels in the brain are resonating"; TINNITUS (non-serious) with onset Jul2021, outcome "unknown", described as "buzzing sounds"; HEAD DISCOMFORT (non-serious) with onset Jul2021, outcome "not recovered", described as "feels as if I am being punched/assaulted at the base of my skull"; HEADACHE (non-serious) with onset Jul2021, outcome "not recovered", described as "headaches are intense/pounding headaches"; MIGRAINE (non-serious) with onset Jul2021, outcome "not recovered", described as "intense migraine attacks"; PALPITATIONS (non-serious) with onset Jul2021, outcome "not recovered", described as "pounding heartbeat"; ANXIETY (non-serious) with onset Jul2021, outcome "not recovered", described as "worried". The events "feels as if i am being punched/assaulted at the base of my skull", "worried", "pounding heartbeat", "intense migraine attacks", "buzzing sounds", "headaches are intense/pounding headaches" and "blood vessels in the brain are resonating" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of head discomfort, anxiety, palpitations, migraine, tinnitus, headache, cerebrovascular disorder. Additional information: COVID tested post vaccination. No other vaccine in four weeks. No other medication with in two weeks. Sender's Comments: Linked Report(s) : PFIZER INC-202201038243 Same reporter/Patient/AE, different Dose.
inflammation of injection site; Pain of injection site; More difficulty breathing than normal; hands were trembling; Dizziness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (More difficulty breathing than normal), TREMOR (hands were trembling), VACCINATION SITE INFLAMMATION (inflammation of injection site), DIZZINESS (Dizziness) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression, Hypertension, Anxiety, Cholesterol, Multiple sclerosis, Pollen allergy, Sun sensitivity and Smoker. Concomitant products included GABAPENTIN and MULTI VITAMIN & MINERAL for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Fatigue). On 24-Apr-2021, the patient experienced DYSPNOEA (More difficulty breathing than normal) and TREMOR (hands were trembling). On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (inflammation of injection site) and VACCINATION SITE PAIN (Pain of injection site). At the time of the report, DYSPNOEA (More difficulty breathing than normal), TREMOR (hands were trembling), VACCINATION SITE INFLAMMATION (inflammation of injection site), DIZZINESS (Dizziness), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included paracetamol and an anti-inflammatory drug.
Primary Pfizer Covid dose, 30MCG Gray cap, given 9/12/2022 Pfizer Bivalent Covid Booster given 10/3/2022 instead of second dose Pfizer primary vaccine  Per CDC guidance, patient notified that another dose of Pfizer would NOT be required and that the Booster he received would count as his second Primary dose
pt recv vax 21SEP95 & presented w/acute varicella infect 3MAY96;vaccine failed to prevent acute infection
Information has been received from a nurse practitioner concerning a patient who was vaccinated in the past (date uncertain) with a dose of VAQTA. At an unspecified date the patient had a "negative titer". The patient sought unspecified medical attention. A product quality complaint was not involved. Additional information has been requested.
almost 24 hours to the minute after receiving the vaccination i had fever, chills, extreme nausea, headache, muscle pain , weakness.  even touching my eyebrows hurt.  it lasted 10 hours during which time I did not take any medications, eat or drink anything.  I did not seek treatment and by morning I was wiped out but all symptoms had resolved.
This spontaneous report has been received from a medical assistant concerning a 65 year old female patient. The patient's concurrent conditions included multiple sclerosis since April 2017. Concomitant therapies included several unknown hypertension medications. The patient had no drug reactions or allergies. On 03-OCT-2017 the patient was vaccinated with PNEUMOVAX 23)with lot number N013521 and expiration date on 23-JAN-2019 (dose, dose number and anatomical location were not provided), administered intramuscularly for prophylaxis. On 03-OCT-2017, after getting the vaccine, the patient experienced swelling (peripheral swelling) and redness of whole upper arm down to elbow (erythema). It was reported that an unspecified treatment was given for the events. No lab diagnostics or studies were performed. At the time of reporting, the patient was recovering from peripheral swelling and erythema and the causal relationship between PNEUMOVAX 23 and the events was unknown.   This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-1710USA002314:
Injection site is red and hot to the touch. Arm looks swollen. Reaction started 3-4 days after injection
Expired vaccine used; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used).    The case reported for 115 of 190 Cases.  No concomitant medication was provided by reporter.  190 patients (9 different lot numbers) received a vaccine past the beyond used by date  No treatment information was provided by the reporter.
Patient received a J&J vaccine on 3/16/21 at School at approximately 3:26 p.m. Patient completed the 15 min monitoring and was able to depart the facility at 3:41 p.m. Approximately 5 mins after departure the patient noticed numbness in her RIGHT cheek/face and was drooling when she attempted to drink water. The patient immediately returned to the vaccine site to report the reaction. Medical staff evaluated for any emergent care needed. Patient is alert and oriented x4, ambulates without difficulty, no nausea/vomiting/fever, no lightheadedness noted. Patient reports symptoms are numbness of the RIGHT cheek/face with sensation changes noted up to the RIGHT brow. Patient states the area feels like after you have had a dental procedure and the area feels numb and heavy. The patient also noticed her RIGHT hand feels like it is waking up after going to sleep. After approximately 45 mins of monitoring, the symptoms are decreasing in intensity and she can feel the inside of her cheek as there is less numbness. School nurse completed a basic neurological cheek, arm strength is within normal limits, patient?s face is symmetric, and she can stick out her tongue. The patient has notified her spouse and a friend whose house she plans to drive to for additional support. The patient has been educated on OTC medications to support her recovery and to seek ER treatment if her symptoms worsen. The patient declines medication offered at this time such as Benadryl. The patient has been advised to notify her primary care physician for further evaluation and follow-up care. Patient reports she does feel better and feels ready to depart at approximately 5:45 p.m.
Unusual pain with injection. By evening was very sore and had to take medication during the night. Next day I was unable to take off my sports bra without assistance due to pain.  Pain has persisted over 2 months.  Severity waxes and wanes but it?s always present, esp with exercise.
Hot to the touch at the injection site; Broke out with a rash on the arm around the injection site which looks like a solid lump; Itchiness at the injection site; Broke out with a rash on the arm around the injection site which looks like a solid lump; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to the touch at the injection site), VACCINATION SITE MASS (Broke out with a rash on the arm around the injection site which looks like a solid lump), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE RASH (Broke out with a rash on the arm around the injection site which looks like a solid lump) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch at the injection site), VACCINATION SITE MASS (Broke out with a rash on the arm around the injection site which looks like a solid lump), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE RASH (Broke out with a rash on the arm around the injection site which looks like a solid lump) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (Hot to the touch at the injection site) was resolving and VACCINATION SITE MASS (Broke out with a rash on the arm around the injection site which looks like a solid lump), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE RASH (Broke out with a rash on the arm around the injection site which looks like a solid lump) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Thousands of tiny to moderate sized cherry angiomas showed up all over my body in the next few days and months. They were located primarily on the tops of my thighs, the tops of my arms, my stomach, my chest and a few tiny ones on my face. Prior to the vaccine, I had only three small cherry angiomas on my body.
This spontaneous prospective pregnancy report as received from a Registered Nurse refers to a 32 year old female patient with no pertinent medical history and no drug reactions/allergies. On 03-APR-2013 the patient was vaccinated IM into her left deltoid with a 0.5 ml dose of GARDASIL (lot # H013977, expired on 19-MAR-2015) instead of the intended Tdap vaccine (manufacturer unknown). There was no concomitant medication. The patient pregnant gestation was 32 weeks and 6 days. The last menstrual period (LMP) was on 21-SEP-2012 and estimated date of delivery (EDD) on 28-JUN-2013. The patient did not seek medical attention. Additional information has been requested.
Vaccine triggered or caused stroke-like migraines with hemiparesis/hemiplegia.
I had trouble gripping things with my hand. I couldn't get out of a chair or out of bed without help. I had aches all over my body. I had a very low energy level. My joints were very stiff. I had some swelling in my hands, fingers and wrist area. I had a low grade fever. In 2020 I average walking 9 miles everyday. After the shot I could barely walk from the kitchen to the bedroom without being tired. I lost about 15 pounds. I had a cough off and on. I slept all the time. My appetite was limited. I have concerns about receiving the booster vaccine after experiencing the reactions to the 2nd dose. I also have a concern on whether or not my booster should be Pfizer or switch to Johnson and Johnson.
Intense abdominal pressure began approx 18 hours after shots. Followed by nausea and several strong bouts of vomiting. Then intense chills (teeth chattering) with no fever. Vomiting over 8hr period. Chills lasted several hours. Following day (48 hrs post injection) had fever of 101.7 for most of day. Some ongoing nausea. Strong fatigue. Day 3 post injection, continued fever but lower - 100.7 along with fatigue. Sweats and headache. Covid shot arm became more sore. Day 4 had minor fever 99.6 but very low energy and still unable to work. Feeling of weakness / fatigued muscles along with difficulty concentrating and some light headedness continued for 2 more days. All symptoms finally gone today - one week subsequent to injections.
Fever, achy all over, arm and shoulder pain, other pain consistent with joint inflammation, fatigue, headache. Concerning  event was chest pain in the  center and  of my chest and a bit to each side.
Information has been received from a RN concerning a 26 year old female who as a child was vaccinated with a dose of varicella virus vaccine live. The RN reported that in approximately 2005, the pt did not show seroconversion after a titer. Unspecified medical attention was sought. At the time of the report, the outcome was unknown and no other sx were noted. Additional information has been requested.
Nausea, chills, fever 101.2, headache, dizzinessstarted 11am the next day by 3pm i left work and went to bed slept 7 hours, up for 2 hours slept for 8 hours.   Took theraflu hot drink when i got home 3:30 pm another at 10pm thursday 8:30 am still had headache took 2 ibuprofen.  Better now at 3pm
This spontaneous report was received from a pharmacist regarding 3 unspecified patients of unknown age and gender. The medical history of patients and their concurrent conditions were not reported. On 31-MAR-2016, 3 unspecified patients were inadvertently vaccinated with expired doses of PNEUMOVAX 23 (Lot # K009874, expiry date 19-MAR-2016) dosage regimen and route unknown. Concomitant medications were not reported. No adverse effects were reported. Product quality complaint (PQC) was not filed. Additional information has been requested.
Day 3 after the vaccine in the morning my left armpit was extremely swollen and sore. A gland around my clavicle was also swollen, it stayed this way for a week so I called the clinic who explained VAERS to me which I could not access.
This spontaneous report as received from a registered nurse refers to unknown number of patients (unknown age and gender). The nurse reported that improperly stored GARDASIL might have been administered to an unknown number of patients on unspecified dates. Lot# and administration information were not provided. No adverse effects reported. This is one of two reports received from the same reporter. Additional information is not expected.
Headache, fever, fatigue, myalgia, chills, shaking, weakness, arthralgia fingers, arms, shoulders, back, legs, lack of appetite Tylenol every 4 hours Symptoms continue
neuropathy; couldn't walk or coudn't move; felt sick; nauseous; severe throbbing headache; muscle pain; joint pain; A spontaneous report was received from a consumer concerning a 57 years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced neuropathy (medically significant), couldn't walk and couldn't move, felt sick, nauseous, severe throbbing headache, muscle pain, and joint pain.  The patient's medical history included brittle diabetes, thyroid issues and neuropathy. Concomitant medications included clonazepam and melatonin.   The patient received their first of two planned doses of mRNA-1273 (lot/batch 038K20A) on 25 Jan 2021.  On 22 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch 007M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 22-Feb-2021, post vaccination, the patient felt sick all night which lasted until  25 Feb 2021.  The patient described feeling nauseous, had a severe throbbing headache, muscle pain, joint pain, and neuropathy. Patient reported past neuropathy but not like this where patient couldn't walk and couldn't move.   Treatment details included 500 mg of paracetamol.   The patient received both planned doses of mRNA-1273; therefore action taken with mRNA-1273 in response to the events was not applicable.  The events neuropathy, couldn't walk and couldn't move, felt sick, nauseous, severe throbbing headache, muscle pain and joint pain were considered recovered / resolved on 25 Feb 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.